bluebird bio Operating Expenses 2011-2026 | BLUE

Annual Operating Expenses bluebird bio

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	854 M	623 M	367 M	270 M	180 M	85.8 M	45.1 M	24.1 M	16 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
854 M	16 M	274 M

Quarterly Operating Expenses bluebird bio

2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	176 M	161 M	156 M	133 M	121 M	85.4 M	84.5 M	76.7 M	73.9 M	79.7 M	61.5 M	58.9 M	50.4 M	44.5 M	57 M	31.3 M	26 M	23.4 M	19.7 M	17 M	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
176 M	17 M	76.9 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Anika Therapeutics ANIK	51.6 M	$ 14.93	0.88 %	$ 219 M	USA
Aptorum Group Limited APM	20.7 M	$ 0.93	0.51 %	$ 5.07 M	China
Aquestive Therapeutics AQST	85.5 M	$ 4.14	0.36 %	$ 443 M	USA
Arcturus Therapeutics Holdings ARCT	158 M	$ 8.39	4.5 %	$ 230 M	Israel
Ardelyx ARDX	95.9 M	$ 6.06	1.94 %	$ 1.46 B	USA
argenx SE ARGX	3.19 B	$ 749.68	0.44 %	$ 25 B	Niderland
Arcutis Biotherapeutics ARQT	137 M	$ 23.93	1.27 %	$ 3.04 B	USA
Arvinas ARVN	381 M	$ 11.36	4.7 %	$ 805 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Arrowhead Pharmaceuticals ARWR	731 M	$ 61.99	1.57 %	$ 8.29 B	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Assembly Biosciences ASMB	84.4 M	$ 29.09	0.28 %	$ 326 M	USA
Actinium Pharmaceuticals ATNM	36.3 M	$ 1.13	15.26 %	$ 35.3 M	USA
Atossa Therapeutics ATOS	37.1 M	$ 5.19	-3.36 %	$ 44.7 M	USA
Atara Biotherapeutics ATRA	361 M	$ 5.0	0.2 %	$ 62.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Aurinia Pharmaceuticals AUPH	43.9 M	$ 16.05	2.79 %	$ 2.16 B	Canada
Autolus Therapeutics plc AUTL	145 M	$ 1.41	-0.35 %	$ 375 M	Britain
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Axon Enterprise AXON	1.18 B	$ 411.97	-0.2 %	$ 31.2 B	USA
Aytu BioScience AYTU	53.7 M	$ 2.65	-1.12 %	$ 16.6 M	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
BioCardia BCDA	15.7 M	$ 1.18	-1.67 %	$ 7.87 M	USA
BioCryst Pharmaceuticals BCRX	144 M	$ 9.59	6.26 %	$ 1.98 B	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA
Anavex Life Sciences Corp. AVXL	51.4 M	$ 3.05	1.51 %	$ 260 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.07 B	$ 9.46	-3.47 %	$ 612 M	USA
BioVie BIVI	18.1 M	$ 1.46	2.81 %	$ 2.16 M	USA
BioLineRx Ltd. BLRX	28.1 M	$ 2.32	4.98 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	1.47 B	$ 56.04	0.96 %	$ 10.7 B	USA
BioNTech SE BNTX	512 M	$ 91.64	0.5 %	$ 27.2 B	Germany
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
BioXcel Therapeutics BTAI	107 M	$ 1.18	-0.42 %	$ 14.4 M	USA
Burford Capital Limited BUR	106 M	$ 4.5	8.57 %	$ 683 M	Britain